[6]-Gingerol is an active component of ginger that shows antipyretic and anti-inflammation activities. To find a novel skin-whitening agent, the melanogeneis inhibitory effects and action mechanisms of [6]-gingerol were investigated. In the present study, the effects of [6]-gingerol on mushroom tyrosinase, tyrosinase activity, and melanin content were determined spectrophotometrically, and the expression of tyrosinase and related proteins in B16F10 murine melanoma cells was evaluated by Western blotting. Furthermore, a possible signaling pathway involved in [6]-gingerolmediated depigmentation was investigated by means of specific inhibitors. The results revealed that [6]-gingerol (25-100 M) effectively suppresses murine tyrosinase activity and decreases the amount of melanin in a dosedependent manner. Additionally, it also effectively decreased the intracellular reactive oxygen species (ROS) level in a dose-dependent pattern in the same dose range. Our results indicate that [6]-gingerol inhibits melanogenesis of B16F10 melanoma and can function as a good skinwhitening agent.
Melanin plays an important role in protecting the skin against ultraviolet light injury, and is responsible for skin color. However, overproduction and accumulation of melanin results in several skin disorders, including freckles, melasma, age spots, and other hyperpigmentation syndromes. 1) Tyrosinase (monophenol, L-dihydroxyphenylalanine or L-DOPA: oxygen oxidoreductase EC 1.14.18.1) is the key enzyme in the first two steps of melanin biosynthesis, in which L-tyrosine is hydroxylated to L-DOPA (an o-diphenol product), and L-DOPA is further oxidized to the corresponding o-quinone.
2) It has been reported that microphthalmia-associated transcriotion factor (MITF) and other enzymes such as phospholipase C (PLC), tyrosinase related protein-1 (TRP-1), and tyrosinase related protein-2 (TRP-2) also contribute to the production of melanin. [3] [4] [5] Recently, melanogenesis inhibitors are increasingly applied in skin care cosmetics to prevent hyperpigmentation. 6) In addition, melanogenesis has been reported to produce hydrogen peroxide (H 2 O 2 ) and other reactive oxygen species (ROS) which puts the melanocytes under lowgrade oxidative stress. It is known that ROS play a significant role in the regulation of melanogenesis, while ROS scavengers and inhibitors of ROS generation can downregulate UV-induced melanogenesis. 7) Hence antioxidants such as ascorbic derivatives and reduced glutathione (GSH) have been applied to inhibit melanogenesis. 8, 9) It has been reported that many phenolic compounds show antioxidant activity and that many naturally occurring inhibitors of melanogenesis have a phenol structure. [10] [11] [12] [6]-Gingerol is an active principle of Zinger officinale Roscope (Zingiberaceae), and is reported to possess various pharmacological activities, including antipyretic effects and anti-inflammation action through inhibition of prostaglandin biosynthesis. 13, 14) It also inhibits mouse skin tumor development 15) and angiogenesis. 16) Additionally, [6] -gingerol has been found to prevent UVB-induced ROS production, 17) but the inhibitory action of [6] -gingerol on melanogenesis has never been explored.
In this study, we attempted to determine the effects of [6] -gingerol on mushroom tyrosinase activity, tyrosinase expression, tyrosinase activity, and melanin content in B16F10 melanoma cells. Moreover, we looked into the inhibitory effect of [6] -gingerol on melanogenesis, which is associated with its antioxidant property, by assessing its free-radical scavenging activities. Furthermore, to examine possible signaling pathways involving [6] -gingerol, we also studied changes in Akt/protein kinase B (PKB) signaling induced by [6] -gingerol.
Materials and Methods
Chemicals. The [6] -Gingerol used in the study was purchased from wako (Osaka, Japan). Its purity was more than 99%. The company guaranteed chemical consistency for high performance liquid chromatography (HPLC), and confirmed biological reliability by lymphocyte proliferation assay. Trichloroacetic acid, glycine, Tris, EDTA, and monosodium and disodium phosphate were from Merck (Darmstadt, Germany). Acrylamide, bisacrylamide, TEMED (N,N,N 0 ,N 0 -tetramethylethylenediamine), Tween 20, and ammonium persulfate were from Bio-Rad (Richmond, CA). All other chemical reagents, mushroom tyrosinase (3320 units/mg), and -MSH (melanocyte stimulating hormone) were from Sigma Chemical (St. Louis, MO). A MicroBCA kit was from Thermo Fisher Scientific (Waltham, USA). Antibodies, including anti-microphthalmia-associated transcription (MITF), anti-TRP1, anti-TRP2, anti-GAPDH and goat anti-mouse antibody conjugated with horseradish peroxidase were from Santa Cruz Biotechnology (Santa Cruz, CA). The ECL reagent was from Millipore (Billerica, MA).
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Assay of mushroom tyrosinase activity. In order to assay the inhibitory action of [6] -gingerol on mushroom tyrosinase, dosedependent inhibition experiments were carried out in triplicate, as described previously, with a minor modification. 18) Briefly, 10 mL of aqueous solution of mushroom tyrosinase (1000 units) was added to a 96-well microplate, in a total volume of 200 mL mixture containing 5 mM L-DOPA which is dissolved in 50 mM phosphate buffer (pH 6.8). The assay mixture was incubated at 37 C for 30 min. Following incubation, the amount of dopachrome produced in the reaction mixture was determined spectrophotometrically at 490 nm (OD 490 ) in a microplate reader. The inhibition percentage at three doses for each experiment was calculated by the following equation: inhibition percentage of tyrosinase activity ð%Þ ¼ ðB À AÞ Ä A Â 100, where B is the mean of the measured OD 490 values of the blank control, and A is the mean of the measured OD 490 values for the [6] -gingerol treated group.
Cell culture. B16F10 cells (ATCC CRL-6475; from the BCRC Cell Line Bank, BCRC60031) were cultured in DMEM with 10% fetal bovine serum (FBS; Gibco BRL, Gaithersburg, MD, USA) and penicillin/streptomycin (100 I.U/50 mg/mL) in a humidified atmosphere containing 5% CO 2 in air at 37 C. All the experiments were performed in triplicate and were repeated 3 times to ensure reproducibility.
Cell proliferation. Cell viability assay of B16F10 was performed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). 19) In brief, 1 Â 10 4 cells/well was seeded into a 96-well plate. The cells were exposed to [6] -gingerol at concentrations of 25, 50, and 100 mM for 24 h, then MTT solution was added to the wells. The insoluble derivative of MTT produced by intracellular dehydrogenase was solubilized with ethanol-DMSO (1:1 mixture solution). The absorbance of the wells at 570 nm was read using a microplate reader.
Measurement of melanin content. The intracellular melanin content was measured as described by Tsuboi et al., 20) with some modifications. The cells were treated with -MSH (100 nM) for 24 h, and then the melanin content was determined after treatment with either [6]-gingerol (0-100 mM) or kojic acid (200 mM) for a further 24 h.
After treatment, the cells were detached by incubation in trypsin/ ethylenediaminetetraacetic acid (EDTA). After precipitation, cell pellets containing a known number of cells were solubilized in 1 N NaOH at 60 C for 60 min. The melanin content was assayed by spectrophotometric analysis at an absorbance of 405 nm.
Assays of intracellular tyrosinase activity. Cellular tyrosinase activity was determined as described previously, 21) with slight modifications. Briefly, the cells were treated with -MSH (100 nM) for 24 h, and then intracellular tyrosinase activity was measured after treatment with various concentrations of [6]-gingerol (0-100 mM) or kojic acid (200 mM) for 24 h. After these treatments, the cells were washed twice with phosphate-buffered saline and homogenized with 50 mM PBS (pH 7.5) buffer containing 1.0% Triton X-100 and 0.1 mM PMSF. Intracellular tyrosinase activity was monitored as follows: Cell extracts (100 mL) were mixed with freshly prepared L-DOPA solution (0.1% in phosphate-buffered saline) and incubated at 37 C. The absorbance at 490 nm was measured with microplate reader Gen 5Ô (BIO-TEK Instrument, Bermont, USA) to monitor the production of dopachrome, corrected for auto-oxidation of L-DOPA.
Western blotting. B16F10 cells, treated with [6]-gingerol or not, were washed twice with cold phosphate-buffered saline (PBS), lysed in PBS containing 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 5 mg/mL of aprotinin, 100 mg/mL of phenylmethylsulfonyl fluoride, 1 mg/mL of pepstatin A, and 1 mM EDTA at 4 C for 20 min, and then disrupted with a needle. Total cell lysates were quantified using a microBCA kit. Proteins (50 mg) were resolved by SDS-polyacrylamide gel electrophoresis and electrophoretically transferred to a polyvinylidene fluoride (PVDF) filter. The nylon filter was blocked for 1 h in 5% fat-free milk in PBST buffer (PBS with 0.05% . After a brief wash in the PBST buffer, the nylon filter was incubated overnight at 4 C with antibodies (antimicrophthalmia-associated transcription (MITF) antibody (1:1,000), anti-TRP1 antibody (1:2,000), anti-TRP2 antibody (1:2,000), anti-PLC (1:200), anti-pPLC (1:500), anti-GAPDH antibody (1:3,000), and antityrosinase antibody (1:2,000) (Epitomics, Burlingame, CA). Then the primary antibody was removed, and the filter was further washed extensively in PBST buffer. Subsequent incubation with goat antimouse antibody (1:10,000) conjugated with horseradish peroxidase was conducted at room temperature for 2 h. The filter was washed extensively in PBST buffer to remove the secondary antibody, and the blot was visualized with ECL reagent. The relative amounts of MITF and tyrosinase, compared to total GAPDH, and of phospho-PLC normalized to the PLC were calculated and analyzed with Multi Gauge 3.0 software (Fuji, Tokyo). Values represent the mean for triplicate experiments AE standard deviations, ÃÃ p < 0:01 vs. control.
Cellular ROS level determination. B16F10 melanoma cells were cultured in 24-well plates (5 Â 10 4 cells in 1 mL of DMEM medium) and treated with various concentrations of [6]-gingerol (0-100 mM) for 24 h. The cells were then incubated with 24 mM H 2 O 2 at 37 C for 30 min. After incubation, 2 0 ,7 0 -dichlorofluorescein diacetate (DCFH-DA) was added to the wells, and the cells were cultured for 30 min. After treatment, the cells were washed with phosphatebuffered saline, and trypsinized by trypsin/EDTA, and the fluorescence intensities of DCF were measured at excitation wavelength 504 nm and emission wavelength 524 nm using a fluorescent reader Fluoroskan Ascent (Thermo Scientific, Vantaa, Finland). The data were analyzed with Ascent software (Thermo Scientific, Vantaa, Finland). Cells with increased ROS contents, appeared as a population with a higher fluorescence intensity. 22) Statistical analysis. Statistical analysis of the experimental data was performed by ANOVA test, which was used for comparison of measured data using SPSS 12.0 statistical software (SPSS, Chicago). Differences were considered statistically significant at p < 0:05.
Results
Effect of [6] -gingerol on mushroom tyrosinase activity Tyrosinase plays an important role in the melanin synthesis process. It converts L-tyrosine to L-DOPA and oxidizes L-DOPA to form dopachrome. The results indicate that mushroom tyrosinase activity was not inhibited by the various concentrations of [6]-gingerol (0-100 mM), but 200 mM of kojic acid inhibited tyrosinase activity, and enzyme activity was only 64.13% of that of control.
Effect of [6]-gingerol on B16F10 cell viability
To assess the effect of [6] -gingerol on cell viability, B16F10 melanoma cells were treated with various concentrations of [6]-gingerol (0-100 mM) for 24 h. The MTT assay is a colorimetric assay to measure the activity of enzymes that reduce MTT to formazan dyes, giving a purple color. Results are expressed as percent viability relative to control (0 mM). It can also be used to determine the cytotoxicity of potential medicinal agents and toxic materials, since those agents stimulate or inhibit cell viability and growth. After treatment, [6] gingerol had no significant effect on cell proliferation (95% at 25 mM, 93% at 50 mM, and 90% at 100 mM).
Effect of [6]-gingerol on melanin content in B16F10 cells
To determine the effect of [6] -gingerol on melanogenesis, B16F10 melanoma cells were stimulated with 100 nM -MSH for 24 h and cultured in the presence of [6] -gingerol at 5, 10, 20, 25, 50, 100 mM or kojic acid (200 mM) for another 24 h. Treatment with [6]-gingerol at 25-100 mM showed a significant inhibitory effect on melanin synthesis in a dose-dependent manner in the B16F10 melanoma cells that pretreated with -MSH. The melanin content was represented as percentage of control (0 mM of [6]-gingerol). After treatment, the melanin content was 66.25% at 25 mM, 61.15% at 50 mM, and 56.66% at 100 mM (Fig. 2) . Meanwhile, B16F10 melanoma cells were treated with kojic acid (200 mM) as positive standard, and the melanin content was 66.13% of control (Fig. 2) . The results shown in Fig. 2 indicate that [6] -gingerol has a more potent inhibitory effect on melanin formation in B16F10 melanoma cells than kojic acid does.
Inhibitory effect of [6]-gingerol on B16F10 tyrosinase activity
To examine the possible mechanism of the inhibitory effect of [6] 
[6]-Gingerol at 25-100 mM significantly inhibited -MSH-induced tyrosinase activity in a dose-dependent pattern (Fig. 3) . After these treatments, the remaining B16F16 intracellular tyrosinase activity was 58.25% at 25 mM, 56.97% at 50 mM and 43.10% at 100 mM. Meanwhile, the intracellular tyrosinase activity was 60.40% after the cells were treated with kojic acid (200 mM).
The results shown in Fig. 3 were in accordance with those indicated in Fig. 2 , which means that [6] -gingerol inhibited intracellular tyrosinase activity and then decreased the melanin content in a dose-dependent manner in the B16F10 melanoma cells.
Effect of [6]-gingerol on cellular melanogenesisrelated protein expression
Recently it was reported that many proteins are involved in tyrosinase expression, including microphthalmia-associated transcriotion factor (MITF), phospholipase C (PLC), tyrosinase related protein-1 (TRP-1), and tyrosinase related protein-2 (TRP-2). To test whether [6] -gingerol does regulate the expression of these proteins, B16F10 melanoma cells were treated with -MSH (100 nM) for 24 h, and then 25, 50, and 100 mM of [6] -gingerol or kojic acid (200 mM) was added for 24 h. MITF, PLC, TRP-1, and TRP-2 levels were assayed by Western blot (Fig. 4A) . It was found that 50 mM [6]-gingerol treatment led to a significantly reduced level of MITF and a slight decrease in tyrosinase (Fig. 4B) , but the protein contents of PLC, TRP-1 and TRP-20 were not obviously different after [6] -gingerol treatment (Fig. 4A ). Additionally, the expression level of phosphorylated PLC (p-PLC) was enhanced after [6] gingerol stimulation. Furthermore, the effect of a lower concentration (25 mM) was stronger than that of a higher one (100 mM) of [6] -gingerol (Fig. 4B) .
Effect of IBMX and LY294002 on melanin synthesis in B16F10 melanoma cells
To understand the postulated signaling mechanism involved in the inhibitory effect of [6] -gingerol on melanin synthesis in cultured B16F10 melanoma cells, cells were treated with 100 nM -MSH for 24 h, and then 10 mM of various protein kinase regulators, including 3-isobutyl-1-methylxanthine (IBMX), LY294002 (phosphatidylinositol-3-kinase inhibitor) (PI 3K inhibitor), SB203580 (p38 MAPK-inhibitor), SP600125 (c-Jun N-terminal kinase inhibitor; JNK inhibitor), H89 (cAMP-dependent protein kinase inhibitor), U0126 (MEK 1-inhibitor), PD98059 (MEK 1/2-inhibitor), and GF 109203X (classical PKC inhibitor), were added for 4 h. After these treatments, 50 mM of [6] -gingerol and 10 mM of the above kinase regulators were added and incubated for 20 h. The melanin contents were assayed and expressed as percentage of control. As shown in Fig. 5 , melanin synthesis was significantly induced after treatment with IBMX, and LY294002 also promoted melanin production.
Effect of [6]-gingerol on the ROS generation in B16F10 cells
To confirm the capacity of [6] -gingerol to scavenge free radicals in a cellular environment, evaluation of intracellular ROS levels was done. The principle of the assay is that DCFH-DA diffuses through the cell membrane and is enzymatically hydrolyzed by esterase to DCFH, which reacts with ROS (such as H 2 O 2 ) to yield DCF. Rapid increases in DCF indicate oxidation of DCFH by intracellular radicals. 23) The concentration of H 2 O 2 employed was 20 mM. In this assay, [6] -gingerol inhibited the intracellular ROS induced by H 2 O 2 by 52.6% at 25 mM, 46.2% at 50 mM and 42.0% at 100 mM (Fig. 6 ).
Discussion
[6]-Gingerol (1-[4 0 -hydroxy-3 0 -methoxyphenyl]-5-hydroxy-3-decanone) is a major pungent and pharmacologically active compound of ginger, as shown in Fig. 1 . It has been reported that [6] -gingerol possesses many interesting activities, such as antipyretic effects and antiinflammation activity, but there is no report on the effect of [6] -gingerol on melanin production. In the present study, we identified a possible inhibitory mechanism of [6] -gingerol on melanogenesis in B16F10 murine melanoma cells. Although [6] -gingerol did not show any inhibitory effect on mushroom tyrosinase activity, it inhibited intracellular tyrosinase activity and melanin production in B16F10 cells. In these experiments, -MSH was used as a cAMP inducer to stimulate melanin synthesis.We found that -MSH can bind melanocortin 1 receptor (MC1R) and activate adenylate cyclase, what in turn catalyzes ATP to cAMP and increases intracellular cAMP level. 24) Our results indicate that [6] gingerol inhibited the melanogenesis induced by -MSH mediated intracellular cAMP upregulation.
Tyrosinase, TRP-1, and TRP-2 are key factors in melanin synthesis. 5, 25) To investigate the inhibitory effect of [6] -gingerol on melanogenesis,Western blotting was performed to evaluate the amounts of tyrosinase, Fig. 1 . Chemical Structure of [6] -Gingerol.
[6]-Gingerol Inhibits MelanogenesisTRP-1 and TRP-2, and other melanogenesis-related proteins such as MITF, PLC, and phosphorylated PLC. As shown in Fig. 4, [6] -gingerol inhibited tyrosinase expression in a dose-dependent manner, but it had no influence on TRP-1 or TRP-2 expression. Additionally, [6] -gingerol decreased the expression of MITF. Thus [6] -gingerol can influence tyrosinase at the transcription level, and melanin production was down-regulated.
To elucidate the effect of [6] -gingerol on melanin production, we treated B16F10 melanoma cells with [6] gingerol and observed a dramatic inhibition of melanin content on increasing the concentration of [6] -gingerol in the culture medium (Fig. 2) . In this assay, kojic acid was used as a positive standard agent. It is reported to affect melanin synthesis in melanocytes and melanoma cells. 26) Our results indicate that the inhibitory effect of [6]-gingerol (50, 100 mM) on melanin production was stronger than that of kojic acid (200 mM). The inhibitory effect of 25 mM [6]-gingerol was almost equivalent to that of kojic acid, but we found that less than 25 mM [6]-gingerol had only a minor inhibitory effect on melanogenesis (Fig. 2) . To investigate the action of [6] -gingerol on melanin synthesis, we studied the effect of [6] gingerol on intracellular tyrosinase activity in B16F10 melanoma cells. Tyrosinase is the rate-limiting enzyme in the process of melanin synthesis. In the present study, it was found that [6]-gingerol (25-100 mM) inhibited intracellular tyrosinase activity significantly in a dosedependent pattern, and that the inhibitory effect of [6] gingerol was stronger than that of kojic acid (Fig. 3) . However, lower doses of [6]-gingerol did not decrease intracellular tyrosinase activity effectively. [6]-Gingerol (25-100 mM) did not suppress mushroom tyrosinase activity in the cell-free system, whereas kojic acid inhibited tyrosinase directly. These results suggest that [6] -gingerol decreased melanin production can be attributed to inhibitory action on the signaling pathway regulating tyrosinase activity.
Several signal pathways for enhancE melanin synthesis. The cAMP-mediated pathway is a well-known melanin synthesis cascade. It has been reported that enhanced intracellular cAMP levels can activate protein kinase A (PKA), which subsequently phosphorylates cAMP response binding protein (CREB). CREB binds the cAMP response element (CRE) motif of the MITF promoter and then activates MITF gene transcription. 24) IBMX is a cAMP-elevating agent that increases intracellular cAMP content by inhibiting cAMP phosphodiesterase. 27 ) IBMX stimulated melanogenesis in the presence of [6] -gingerol (Fig. 5) . To identify the signal- ing pathway of [6] -gingerol, we studied the effects of various protein kinase inhibitors on melanogenesis in [6] -gingerol-treated B16F10 melanoma cells. Since LY294002 is a PI3K inhibitor, it increased melanin production ( Fig. 5) , which suggests that [6] -gingerol inhibits melanin synthesis in B16F10 melanoma cells through activation of PI3K pathway signaling. Previous studies have shown that activation of Akt is responsible for suppression of melanin synthesis in G361 melanoma cells, 28) and that specific inhibition of the Akt pathway by LY294002 stimulates melanin synthesis in B16 melanoma cells. 29) In the present study, LY294002 treatment also increased melanin synthesis in B16F10 melanoma cells treated with [6] -gingerol (Fig. 5) . Thus our results are in agreement with earlier studies, which indicate that the Akt pathway is involved in melanin synthesis in B16F10 melanoma cells.
It reported that -MSH stimulates B16 melanoma cell differentiation, characterized by increased melanin synthesis, and that overexpression of phospholipase D1 (PLD1) resulted in marked inhibition of melanin production induced by -MSH, 30) but no potential role of phospholipase C (PLC) in melanin synthesis has been reported. We found that [6] -gingerol increased the expression of phosphorylated phospholipase C (p-PLC) while [6] -gingerol did not affect PLC expression (Fig. 4) . PLC is responsible for phosphatidyl inositol 4,5-bisphosphate (PIP2) turnover, and the products of this reaction are inositol 1,4,5-triphosphate (InsP 3 ) and diacylglycerol (DAG), both of which function as secondary messengers. In this cascade, DAG remains on the cell membrane and activates the signal cascade by activating protein kinase C (PKC). PKC in turn activates other cytosolic proteins by phosphorylating them. Hence an attempt will be made to elucidate the potential roles of PLC and the PKC signaling pathway in [6] -gingeroltreated B16F10 melanoma cells.
The skin is exposed to sunlight and environmental oxidizing pollutants and thus is a locus of oxidative stress. It reported that ultraviolet irradiation induces the formation of reactive oxygen species (ROS) in cutaneous tissue, provoking toxic changes such as lipid peroxidation and enzyme inactivation. 31) To counteract this oxidative damage, the skin is equipped with a network of enzymatic and non-enzymatic antioxidant systems. In the present study, it was found that [6]-gingerol (25-100 mM) suppressed intrcellular ROS production in a dose-dependent pattern (Fig. 6 ). Thus [6] gingerol appears to be a potential whitening agent that might protect melanoma cells from oxidative injury.
In conclusion, we found that [6] -gingerol inhibited melanin synthesis in murine B16F10 melanoma cells, which might lead to the activation of the Akt/PKB pathway. Moreover, our results indicate that [6] -gingerol decreases the melanogenesis process in melanoma cells by reducing MITF and inhibiting tyrosinase activity, which we suggest may be the result of Akt activation and depletion of the intracellular ROS content. Cells were treated with -MSH (100 nM) for 24 h, and then cultured with 10 mM of various kinase regulators for 4 h. After these treatments, [6] -gingerol (50 mM) and inhibitors (10 mM) were added and incubated for another 20 h. Data are shown as mean AE SD.
ÃÃÃ p < 0:001, ### p < 0:001. ÃÃÃ p < 0:001.
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